Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy

Published:2016-01-27 Issue:5 Volume:5 Page:806-815
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Latimer Nicholas R.¹,Bell Helen¹,Abrams Keith R.²,Amonkar Mayur M.³,Casey Michelle⁴

Affiliation:

1. School of Health and Related Research University of Sheffield Sheffield United Kingdom

2. Department of Health Sciences University of Leicester Leicester United Kingdom

3. Novartis Pharmaceuticals Corporation East Hanover New Jersey

4. Pfizer Collegeville Pennsylvania

Funder

GlaxoSmithKline

National Institute for Health Research

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.643

Reference30 articles.

1. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

2. Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

3. Distinct Sets of Genetic Alterations in Melanoma

4. Mutations of the BRAF gene in human cancer

5. NRAS mutation status is an independent prognostic factor in metastatic melanoma

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment-Switching Adjustment of Overall Survival in CheckMate 227 Part 1 Evaluating First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy for Metastatic Nonsmall Cell Lung Cancer;Clinical Lung Cancer;2024-06

2. Unaddressed Challenges in the Treatment of Cutaneous Melanoma?;Medicina;2024-05-28

3. Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances;International Journal of Molecular Sciences;2024-03-04

4. Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer;British Journal of Cancer;2023-09-11

5. Compliance-Adjusted Estimates of Aspirin Effects Among Older Persons in the ASPREE Randomized Trial;American Journal of Epidemiology;2023-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3